Medical ozone alleviates acute lung injury by enhancing phagocytosis targeting NETs via AMPK/SR-A1 axis
2024

Medical Ozone Therapy for Acute Lung Injury

Sample size: 8 publication 10 minutes Evidence: high

Author Information

Author(s): Yan Chenxiao, Zhang Yong, Jin Lai, Liu Xiaojie, Zhu Xuexian, Li Qifeng, Wang Yu, Hu Liang, He Xueming, Bao Hongguang, Zhu Xia, Wang Qian, Liu Wen-Tao

Primary Institution: Nanjing Medical University

Hypothesis

Can medical ozone alleviate acute lung injury caused by sepsis through the AMPK/SR-A1 pathway?

Conclusion

Medical ozone may alleviate sepsis-induced lung injury by enhancing the phagocytosis of neutrophil extracellular traps through the AMPK/SR-A1 pathway.

Supporting Evidence

  • Ozone treatment improved survival rates in mice with sepsis-induced lung injury.
  • Ozone reduced the levels of neutrophil extracellular traps in the lungs.
  • Ozone therapy enhanced lung function and blood flow in treated mice.
  • The therapeutic effects of ozone were nullified in mice lacking the SR-A1 gene.

Takeaway

Ozone therapy can help sick mice breathe better and recover from lung injuries caused by infections.

Methodology

The study used a mouse model of sepsis-induced acute lung injury, measuring survival rates, lung function, and blood flow, along with in vitro experiments on macrophages.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

Male C57BL/6J mice, 6–8 weeks old.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.7555/JBR.38.20240038

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication